Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2013

Jan 24, 2013

30291_dirs_2013-01-24_6585a078-665c-443d-bcbd-fb11448985ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-11-29

Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-29 Common Stock G 5378 Disposed 46292 Direct
2012-11-29 Common Stock G 5378 Acquired 5378 Indirect
2012-11-29 Common Stock G 5378 Disposed 40914 Direct
2012-11-29 Common Stock G 5378 Acquired 5378 Indirect